Dear Private Messenger,
Thank you very much. I don't know if you have HGEN shares, but I hope you have been following and decided to invest here. I further hope you have seen the latest posts, indicating that our CEO appears on his way to becoming our Debtor in Possession.
A Ch 11 bankruptcy was in the script before Kalobios became Humanigen, and a recall of our loaned shares was executed in that time frame, causing a huge short squeeze. I expect to see the same thing repeated, and I think the company could be holding 110M of the 119M shares in our OS. The float could be 192% of our OS.
I hope that bidding has been suppressed due to our lack of regulatory approval. Once Durrant wins the bid, I expect to see news regarding regulatory approvals for CMML and covid. I also think lenz will be used as a vaccine adjuvant for non-mRNA vaccines. This will allow the prophylaxis use of lenz, as well as the therapeutic use.
It was great to hear from you!